Syros Pharmaceuticals announced the appointment of Jason Haas as Chief Financial Officer. Mr. Haas brings more than 25 years of healthcare investment banking and corporate finance experience to Syros. Mr. Haas most recently served as Co-Head of Americas, Healthcare Investment Banking at Barclays, where he executed an array of strategic transactions across the public and private markets, and supported companies through equity and debt financings, mergers and acquisitions, divestitures, and spin-offs. Prior to joining Barclays in 2016, he served as Head of Americas, Healthcare Investment Banking at Deutsche Bank. Prior to his role at Deutsche Bank, he was a Managing Director on the Healthcare Investment Banking team at Goldman Sachs & Co, where he covered life sciences companies. Mr. Haas holds an M.B. A in Finance from Columbia Business School and a B. A in International Relations and Economics from Colgate University.